<ul><li>Swedish MedTech startup MedVasc AB raised €917k in a financing round to support final product development for their catheter device and FDA regulatory approval in the US.</li><li>The funding attracted existing owners and new investors, providing an opportunity to enter the US market.</li><li>MedVasc AB, founded in 2013, has developed the Solutio catheter to enhance anaesthetic procedures for varicose veins treatment, with plans for FDA submission in 2026.</li><li>The company is part of SmiLe's incubator programme in Lund, focusing on advancing life science and FoodTech startups.</li></ul>

Swedish MedTech startup MedVasc raises €917k to improve anaesthetic procedure when treating varicose veins

Discover more